LORI HAKE: Open Payments
NPI 1023106267 · NORMAN, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$374 in 20 payments from 6 companies in 2025. Trend: 2023 $118 · 2024 $162 · 2025 $374
Food & beverage: $374
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 5 | $111 |
| Janssen Pharmaceuticals, Inc | 5 | $88 |
| E.R. Squibb & Sons, L.L.C. | 4 | $69 |
| Alkermes, Inc. | 3 | $53 |
| Teva Pharmaceuticals USA, Inc. | 2 | $36 |
| Neurocrine BioSciences, Inc. | 1 | $18 |
Products named: INVEGA SUSTENNA, COBENFY, ARISTADA, ABILIFY ASIMTUFII, REXULTI, UZEDY, ABILIFY MAINTENA, INGREZZA.
Industry payments across OK — which companies pay providers there.
